Calcium Acetate NDC 76483-086

NDC codes

FDA NDC Directory

Product NDC (as listed)76483-086Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76483-0086Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76483-086-00	76483008600	200 CAPSULE in 1 BOTTLE (76483-086-00)Marketed from May 31, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcium Acetate
Generic name (nonproprietary): calcium acetate
Active ingredients: Calcium acetate — 667 mg/1
Dosage form: Capsule
Route: Oral
Labeler: SQUARE PHARMACEUTICALS LIMITED
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217205
Marketing start: May 31, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 76483-086_6561c80c-48b4-4318-a28c-7cca27cd2885SPL ID 6561c80c-48b4-4318-a28c-7cca27cd2885SPL set ID 5af79d16-31ad-4d68-9a6d-bb5d9c91535dRxCUI 359296UNII Y882YXF34X
Pharmacologic class: Blood Coagulation Factor; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476483008600 followed by a unit qualifier and the quantity

Package 76483-0086-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 3, 2023.

Indications (excerpt from the label)

Calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium acetate capsules are a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217205

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217205
Product	Strength	Form · route	Labeler	Product NDC
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	Nivagen Pharmaceuticals, Inc.	75834-323
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8632
Calcium Acetate	Calcium acetate 667 mg/1	CapsuleOral	PD-Rx Pharmaceuticals, Inc.	72789-422